Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma (Q47746173)

5 February 2018

title

Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma (English)

1 reference

5 February 2018

1 reference

7

Valerie W Rusch

1 reference

5 February 2018

author name string

Santosh Yajnik

1

1 reference

5 February 2018

Kenneth E Rosenzweig

2

1 reference

5 February 2018

Borys Mychalczak

3

1 reference

5 February 2018

Lee Krug

4

1 reference

5 February 2018

Raja Flores

5

1 reference

5 February 2018

Linda Hong

6

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 August 2003

1 reference

5 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

5 February 2018

volume

56

1 reference

5 February 2018

issue

5

1 reference

5 February 2018

page(s)

1319-1326

1 reference

5 February 2018

Surgically debulked malignant pleural mesothelioma: results and prognostic factors

cites work

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Technique for external beam treatment for mesothelioma

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

The importance of surgical staging in the treatment of malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Patterns of failure after trimodality therapy for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Deterioration in lung function following hemithorax irradiation for pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation.

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

Emerging translational therapies for mesothelioma

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00287-6

7 January 2021

10.1016/S0360-3016(03)00287-6

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018